OPTIVEC

What this means for you

Registered since 11 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

90720340

Registration number

6869125

Mark type

Stylized text

Filed

19 May 2021

Published for opposition

26 Jul 2022

Registered

11 Oct 2022

Attorney of record

Christopher M. Hanes

Goods and services

• Class 005 — Pharmaceuticals: Biological preparations for medical use for gene transfer for the treatment of cancer; Biological preparations in the nature of lentiviral particles for DNA, RNA and protein transfer for medical use for the treatment of cancer; all of the foregoing being gene therapy products
• Class 042 — Scientific and technological services: Scientific research and development services in the field of DNA, RNA and protein transfer by lentiviral particles; Scientific research and development services in the field of cell and gene therapies; all of the foregoing in the field of gene therapy

Owner

• Glaxo Group Limited, Brentford, Middlesex,, GB
• Glaxo Group Limited, Stevenage, GB
• Glaxo Group Limited, Brentford, Middlesex,, GB

Prosecution history

• 05 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 05 Jul 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 05 Jul 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 05 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 05 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 08 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 08 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 08 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 11 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 11 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
• 26 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 26 Jul 2022 — PUBLISHED FOR OPPOSITION
• 06 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 23 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 23 Jun 2022 — EXAMINER'S AMENDMENT ENTERED